This video was filmed
in Los Angeles in February 2009, and includes an interview of
the patient and her daughter, who have been flying to the INR
in Los Angeles from Oklahoma on a regular basis for perispinal
etanercept treatment for Alzheimer's. Both mother and daughter
have recently been featured on a TV news piece which was seen
across the country, discussing their positive and sustained results.
Please see Perispinal etanercept for neuroinflammatory disorders. Edward
Tobinick MD. Drug Discovery Today 2009 Feb; 14(3-4):168-77.The
videos above are interviews discussing and documenting the clinical
response to initiation of anti-TNF treatment (perispinal etanercept)
at the INR. For the published results please see
Tobinick E, Gross H, Weinberger A, Cohen H., TNF-alpha Modulation
for Treatment of Alzheimer's Disease: A 6-Month Pilot Study
MedGenMed 2006; 8(2) :25; Tobinick E., Perispinal etanercept
for treatment of Alzheimer's disease, Current Alzheimer
Research 2007 Dec; 4(5):550-2; Tobinick E, Gross H., Rapid
improvement in verbal fluency and aphasia following perispinal
etanercept in Alzheimer's disease, BMC Neurology 2008;
8:27; and Tobinick E., Perispinal etanercept for neuroinflammatory
disorders, Drug Discovery Today 2009 Feb; 14(3-4):168-77.Institute for Neurological Research, a private medical group, inc.
100 UCLA Medical Plaza, Suites 205-210 Los Angeles, California
90095
Video2